Literature DB >> 7900105

Screening of dysfibrinogenaemia using the fibrinogen function versus antigen concentration ratio.

B Krammer1, O Anders, H R Nagel, C Burstein, M Steiner.   

Abstract

The diagnosis of inherited and acquired dysfibrinogenaemia is usually suspected in patients with otherwise unexplained prolonged thrombin time or other tests with thrombin-like enzymes (1). Confirmation of the diagnosis requires discordant results from the investigation of functional fibrinogen and its antigen concentration. However, the issue of the difference between the two results required to confirm dysfibrinogenaemia has rarely been addressed. A difference of at least 0.5 g/l between functional fibrinogen using the method of Clauss and heat precipitation method according to Schulz has been suggested as a prerequisite (1). In the case of acquired dysfibrinogenaemia with an underlying liver disease the discordance should reach at least 1.0 g/l (2). Rodgers and Garr (3) suggested to establish a ratio between fibrinogen function and antigen concentration. In that study plasma from healthy blood donors was investigated using the Clauss method and radial immunodiffusion. We applied this approach to randomly selected patients at the time of admission to a University Hospital Department. Since fibrinogen is one of the major acute phase proteins, the determination of the C-reactive protein (CRP) was included for comparison.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7900105     DOI: 10.1016/0049-3848(94)90287-9

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  6 in total

1.  Natural history of patients with congenital dysfibrinogenemia.

Authors:  Alessandro Casini; Marc Blondon; Aurélien Lebreton; Jérémie Koegel; Véronique Tintillier; Emmanuel de Maistre; Philippe Gautier; Christine Biron; Marguerite Neerman-Arbez; Philippe de Moerloose
Journal:  Blood       Date:  2014-10-15       Impact factor: 22.113

2.  Congenital fibrinogen disorders with repeated thrombosis.

Authors:  Xiuli Zhang; Chuang Zhang; Baoheng Wang; Ningheng Chen; Gaihe Sun; Xueli Guo
Journal:  J Thromb Thrombolysis       Date:  2020-02       Impact factor: 2.300

Review 3.  Clinical Consequences and Molecular Bases of Low Fibrinogen Levels.

Authors:  Marguerite Neerman-Arbez; Alessandro Casini
Journal:  Int J Mol Sci       Date:  2018-01-08       Impact factor: 5.923

4.  Whole Blood Thromboelastometry by ROTEM and Thrombin Generation by Genesia According to the Genotype and Clinical Phenotype in Congenital Fibrinogen Disorders.

Authors:  Timea Szanto; Riitta Lassila; Marja Lemponen; Elina Lehtinen; Marguerite Neerman-Arbez; Alessandro Casini
Journal:  Int J Mol Sci       Date:  2021-02-25       Impact factor: 5.923

5.  [Analysis of gene mutation spectrum and pharmacokinetics of fibrinogen infusion in 146 cases of congenital fibrinogen disorders].

Authors:  L Y Huang; D L Zhang; R F Fu; W Liu; Y F Chen; F Xue; X F Liu; T T Bi; R C Yang; L Zhang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2021-07-14

6.  Development and validation of a novel qualitative test for plasma fibrinogen utilizing clot waveform analysis.

Authors:  Atsuo Suzuki; Nobuaki Suzuki; Takeshi Kanematsu; Sho Shinohara; Hiroshi Kurono; Nobuo Arai; Shuichi Okamoto; Naruko Suzuki; Shogo Tamura; Ryosuke Kikuchi; Akira Katsumi; Tetsuhito Kojima; Tadashi Matsushita
Journal:  Sci Rep       Date:  2022-01-21       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.